webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

(S,E)-TCO2-PEG8-NHS ester

  CAS No.:   Cat No.: BADC-01908 4.5  

(S,E)-TCO2-PEG8-NHS ester is a trans-cyclooctene dimer PEG linker with NHS ester for rapid bioorthogonal conjugation and enhanced payload stability in antibody-drug conjugates. Keywords: ADC linker, PEG linker, trans-cyclooctene dimer, NHS ester, payload conjugation.

(S,E)-TCO2-PEG8-NHS ester

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C32H54N2O14
Molecular Weight
690.78

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-[2-[2-[[(1S,2E)-cyclooct-2-en-1-yl]oxycarbonylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CCC=CC(CC1)OC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
InChI
InChI=1S/C32H54N2O14/c35-29-8-9-30(36)34(29)48-31(37)10-12-39-14-16-41-18-20-43-22-24-45-26-27-46-25-23-44-21-19-42-17-15-40-13-11-33-32(38)47-28-6-4-2-1-3-5-7-28/h4,6,28H,1-3,5,7-27H2,(H,33,38)/b6-4+/t28-/m1/s1
InChIKey
MZIQTDNEOIBQJT-ZPUKQLKQSA-N

(S,E)-TCO2-PEG8-NHS ester is a specialized reagent used in the field of bioconjugation and drug delivery research. Here are some key applications of (S,E)-TCO2-PEG8-NHS ester:

Protein Labeling: (S,E)-TCO2-PEG8-NHS ester is used to covalently attach polyethylene glycol (PEG) molecules to proteins. This process, known as PEGylation, can improve the solubility, stability, and circulation half-life of therapeutic proteins. The biocompatible nature of PEG helps reduce immunogenicity and enhances the therapeutic efficacy of protein-based drugs.

Antibody-Drug Conjugates: In the development of antibody-drug conjugates (ADCs), (S,E)-TCO2-PEG8-NHS ester can be used to conjugate cytotoxic drugs to antibodies. This conjugation improves the selective delivery of drugs to target cancer cells, minimizing side effects on healthy tissues. The PEG linker enhances the stability and bioavailability of the ADCs, making them more effective in cancer therapy.

Surface Modification: (S,E)-TCO2-PEG8-NHS ester is effective in modifying the surfaces of biomaterials and nanoparticles to enhance their biocompatibility and functionalization. By attaching PEG chains to these surfaces, researchers can reduce nonspecific protein adsorption and improve the stability of the materials in biological environments. This is essential for applications in biosensors, drug delivery systems, and tissue engineering.

Cellular Imaging: The ester group in (S,E)-TCO2-PEG8-NHS ester allows for the conjugation of fluorescent dyes or imaging agents to biomolecules, facilitating cellular imaging studies. By labeling proteins or antibodies with fluorescent PEG derivatives, researchers can track and visualize cellular processes in real-time. This is crucial for studying protein localization, cell signaling, and other dynamic cellular activities.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: DBCO-PEG4-vc-PAB-Duocarmycin TM | OSu-PEG4-vc-PAB-DMEA-Duocarmycin SA | OSu-PEG4-vc-PAB-DMEA-Duocarmycin TM | Me-Tet-PEG3-NH2 | MPB-MMAF | DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin SA | Me-Tet-PEG8-NH2 hydrochloride | DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin DM | MAC-VC-PABC-ST7612AA1 | MA-PEG4-vc-PAB-DMEA-duocarmycin DM | FCHFHS-ST7612AA1
Send Inquiry
Verification code
Inquiry Basket